Literature DB >> 2858907

Compliance in the long-term treatment of schizophrenia.

J M Kane, M Borenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858907

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


× No keyword cloud information.
  7 in total

Review 1.  Switching between second-generation antipsychotics: why and how?

Authors:  Monika Edlinger; Susanne Baumgartner; Nadja Eltanaihi-Furtmüller; Martina Hummer; W Wolfgang Fleischhacker
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Unanswered questions in schizophrenia clinical trials.

Authors:  John M Kane; Stefan Leucht
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

3.  Some aspects of the cost of schizophrenia in France.

Authors:  F Rouillon; M Toumi; G Y Dansette; J Benyaya; P Auquier
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 4.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

5.  Medication compliance among the seriously mentally ill in a public mental health system.

Authors:  C Nageotte; G Sullivan; N Duan; P L Camp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-02       Impact factor: 4.328

Review 6.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 7.  Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.